Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia
ABSTRACT Introduction Bruton tyrosine kinase inhibitors (BTKi) are highly effective therapy for chronic lymphocytic leukemia (CLL) but can lead to long‐term side effects. Methods We performed a retrospective analysis of venetoclax consolidation of 20 patients with CLL after initial BTKi discontinuat...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2025-08-01
|
| Sarja: | eJHaem |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/jha2.70085 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|